PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Youyang Zhang

Department of Geriatric Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 8, 2026 · JOURNAL ARTICLE

ZIF-8 nanoplatform coordinating Zn2+ overload and STING activation for enhanced prostate cancer immunotherapy.

International Journal of Pharmaceutics: X

Preclinical in vitro and in vivo study of a novel nanoplatform in experimental models; no clinical trials or human data reported; mechanism-focused work showing promise but not yet tested in patients.

PreliminaryAntitumor Immunity Yifan Ding Youyang Zhang

Study details

DesignPreclinical experimental study (in vitro an…

InterventionNanoplatform PT-c-di-GMP/OVA@ZIF-8 encapsul…

ComparatorAnti-PD-L1 antibody combination tested; no…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support